Wendy Wolf

Wendy Wolf is the current Vice President of Registry & Research at T1D Exchange. Prior to their current position, Wendy served as an Instructor in Pediatrics at Harvard Medical School from January 2013 to December 2015. In this role, Wendy was a co-investigator with the eMERGE Network joint study team across Cincinnati Children’s Hospital Medical Center and Boston Children’s Hospital. Wendy was also the Boston Children's scientific lead for the eMERGE Pharmacogenomics project (NIH/NHGRI U01 HG006828).

From 2010 to 2015, Wendy served as the Executive Director of Biorepositories at Boston Children's Hospital. And from 2003 to 2010, Wendy was a Research Assistant Professor at Northwestern University Feinberg School of Medicine.

In addition to their work in various leadership roles, Wendy has also been active in science policy. Wendy has served as a member of the Science Policy Committee for the International Society for Biological and Environmental Repositories (ISBER) and they have also consulted on multiple NIH-funded grants related to biobanking.

Wendy Wolf completed their PhD in Cell and Molecular Biology at Northwestern University. Prior to that, they completed their BS in Biology at the University of Michigan.

A direct report to Wendy Wolf is and Katherine S. Chapman - Research Manager. Some of their coworkers include Susana Elman - Social Media & Partner Specialist, Brandon Maake - Controller, and Catie Coman - Senior Director Business Development. Their manager is David Walton, CEO.